Hormone Therapy for Prostate Cancer Linked to Depression and a Personal Note of Encouragement.
A large study (see the Cancer Network Oncology link) from Harvard Medical School and Brigham and Women’s Hospital in Boston suggests that men receiving testosterone-suppressing (hormone) therapy (ADT) for prostate cancer may be at increased risk of developing depression. The findings, published online April 11th in the Journal of Clinical Oncology, are based on Medicare … Continue reading “Hormone Therapy for Prostate Cancer Linked to Depression and a Personal Note of Encouragement.”